A new study has found that there is no need to expand the palliative care offered to patients who are suffering from pleural mesothelioma. The study's results showed that palliative care offered earlier for patients did not help to extend the survival rate of patients and did not improve their quality of life. The study's findings were released in Yokohama, Japan, at the World Conference on Lung Cancer.
Patients were analyzed in the United Kingdom and in Australia for this study. The results of the study directly go against a recent recommendation made by the American Society of Clinical Oncology that said palliative care for mesothelioma patients at an earlier stage was important to their care.
Pleural mesothelioma is an aggressive form of mesothelioma and also very rare. Patients diagnosed with this form of mesothelioma typically have just 18 months to live. For the most part, a patient given palliative care will be focused on relieving the symptoms of the disease as much as possible to improve the quality of life before death.
There were 174 patients with mesothelioma involved in the study. The patients were either assigned a palliative care specialist who visited every four weeks or were assigned standard of care by themselves. The assignments were randomly issued.
At the 12-week mark, the study found that there was practically no difference between the two groups that were receiving the different types of care.
Suffering from mesothelioma or any other asbestos-related illness can be overwhelming and painful. An experienced mesothelioma attorney in New Orleans can help you understand your case and how you can protect your rights.
Source: Asbestos.com, "Study Finds No Need to Expand Mesothelioma Palliative Care," Oct. 23, 2017